Hunting Hill Global Capital’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22K Hold
18,395
﹤0.01% 85
2025
Q4
$716 Hold
18,395
﹤0.01% 113
2025
Q3
$692 Hold
18,395
﹤0.01% 120
2025
Q2
$649 Hold
18,395
﹤0.01% 125
2025
Q1
$607 Hold
18,395
﹤0.01% 93
2024
Q4
$859 Hold
18,395
﹤0.01% 89
2024
Q3
$1.47K Hold
18,395
﹤0.01% 68
2024
Q2
$920 Hold
18,395
﹤0.01% 101
2024
Q1
$1.96K Hold
18,395
﹤0.01% 106
2023
Q4
$368 Buy
+18,395
New +$497 ﹤0.01% 114
2023
Q3
Sell
-18,395
Closed -$918 115
2023
Q2
$918 Hold
18,395
﹤0.01% 102
2023
Q1
$692 Hold
18,395
﹤0.01% 72
2022
Q4
$699 Hold
18,395
﹤0.01% 83
2022
Q3
$1K Hold
18,395
﹤0.01% 84
2022
Q2
$2K Buy
+18,395
New +$3.94K ﹤0.01% 81

Other funds holding COCHW

Hunting Hill Global Capital's COCHW Position: Q1 2026 in Review

Hunting Hill Global Capital held its Envoy Medical Warrant (COCHW) position steady in Q1 2026 at 18,395 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #85.

Hunting Hill Global Capital first reported a position in COCHW in Q2 2022 and has held it in 15 quarters since. The position peaked at $2K in Q2 2022. 34 funds tracked by Wall St. Rank hold COCHW as of Q1 2026.

  • Hunting Hill Global Capital held 18,395 shares of Envoy Medical Warrant worth $1.22K as of Q1 2026.
  • Hunting Hill Global Capital left its Envoy Medical Warrant share count unchanged in Q1 2026.
  • Envoy Medical Warrant made up ﹤0.01% of Hunting Hill Global Capital's portfolio in Q1 2026, its #85 holding.
  • Hunting Hill Global Capital first reported a position in Envoy Medical Warrant in Q2 2022 and has held it in 15 quarters since.
  • Hunting Hill Global Capital's Envoy Medical Warrant position peaked at $2K in Q2 2022.
  • 34 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q1 2026.

Based on Hunting Hill Global Capital's 13F filing for Q1 2026, filed 15 May 2026.